LBA3 Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 33; p. S1406
Main Authors: Haanen, J.B.A.G., Rohaan, M., Borch, T.H., van den Berg, J.H., Met, Ö., Foppen, M. Geukes, Granhøj, J. Stoltenborg, Nuijen, B., Nijenhuis, C., Beijnen, J.H., Jedema, I., van Zon, M., Noringriis, I. Mansfield, Kessels, R., Wilgenhof, S., van Thienen, H.V., Lalezari, F., van Akkooi, A.C.J., Donia, M., Svane, I-M.
Format: Journal Article
Language:English
Published: 01-09-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Author van den Berg, J.H.
Nuijen, B.
Haanen, J.B.A.G.
Donia, M.
Foppen, M. Geukes
Wilgenhof, S.
Rohaan, M.
Kessels, R.
Nijenhuis, C.
Beijnen, J.H.
Svane, I-M.
Granhøj, J. Stoltenborg
Met, Ö.
Jedema, I.
Lalezari, F.
van Zon, M.
van Thienen, H.V.
Borch, T.H.
Noringriis, I. Mansfield
van Akkooi, A.C.J.
Author_xml – sequence: 1
  givenname: J.B.A.G.
  surname: Haanen
  fullname: Haanen, J.B.A.G.
– sequence: 2
  givenname: M.
  surname: Rohaan
  fullname: Rohaan, M.
– sequence: 3
  givenname: T.H.
  surname: Borch
  fullname: Borch, T.H.
– sequence: 4
  givenname: J.H.
  surname: van den Berg
  fullname: van den Berg, J.H.
– sequence: 5
  givenname: Ö.
  surname: Met
  fullname: Met, Ö.
– sequence: 6
  givenname: M. Geukes
  surname: Foppen
  fullname: Foppen, M. Geukes
– sequence: 7
  givenname: J. Stoltenborg
  surname: Granhøj
  fullname: Granhøj, J. Stoltenborg
– sequence: 8
  givenname: B.
  surname: Nuijen
  fullname: Nuijen, B.
– sequence: 9
  givenname: C.
  surname: Nijenhuis
  fullname: Nijenhuis, C.
– sequence: 10
  givenname: J.H.
  surname: Beijnen
  fullname: Beijnen, J.H.
– sequence: 11
  givenname: I.
  surname: Jedema
  fullname: Jedema, I.
– sequence: 12
  givenname: M.
  surname: van Zon
  fullname: van Zon, M.
– sequence: 13
  givenname: I. Mansfield
  surname: Noringriis
  fullname: Noringriis, I. Mansfield
– sequence: 14
  givenname: R.
  surname: Kessels
  fullname: Kessels, R.
– sequence: 15
  givenname: S.
  surname: Wilgenhof
  fullname: Wilgenhof, S.
– sequence: 16
  givenname: H.V.
  surname: van Thienen
  fullname: van Thienen, H.V.
– sequence: 17
  givenname: F.
  surname: Lalezari
  fullname: Lalezari, F.
– sequence: 18
  givenname: A.C.J.
  surname: van Akkooi
  fullname: van Akkooi, A.C.J.
– sequence: 19
  givenname: M.
  surname: Donia
  fullname: Donia, M.
– sequence: 20
  givenname: I-M.
  surname: Svane
  fullname: Svane, I-M.
BookMark eNotkM1OwzAQhH0oEm3hDTjsESQSnDhNY26l4idSJCRUztHGcair2K5sp6g8CY9LqnKZ1Yy0O9pvRibGGknITULjhCb5wy5GM0YiTmmaxrSIKcsnZEp5yqLlgmWXZOb9jlKa85RPyW_1tGKwcRKDlibAtwpbCIO2LlKmU31wGJT5gv6o91srjkF6uN2U1R0cpPODB7VXvdKDxgY66wDbAxohW9CyR2M1PsKH9EMfPHTOakDQo1Fi7JLuHhya1mr1My7st-gllGUJwSnsr8hFh72X1_9zTj5fnjfrt6h6fy3XqyoSSZbm0bLBvJEipU2enz6SnAlMRZsgUkbbgiE2DOXouVyIxVIIzpuu40XW8VELNifZ-a5w1nsnu3rvlEZ3rBNan4jWu_pMtD4RrWlRj0TZHznZc_E
CitedBy_id crossref_primary_10_1016_j_ctrv_2022_102499
crossref_primary_10_3390_cancers15194814
crossref_primary_10_1024_1661_8157_a003972
crossref_primary_10_1186_s11658_024_00561_1
crossref_primary_10_3390_cancers15041106
crossref_primary_10_1007_s40257_023_00762_y
crossref_primary_10_1136_jitc_2023_006947
crossref_primary_10_1007_s11864_023_01069_0
crossref_primary_10_1158_1541_7786_MCR_22_0898
crossref_primary_10_1186_s12943_023_01914_8
crossref_primary_10_1080_14712598_2023_2193290
crossref_primary_10_3389_fimmu_2022_1018962
crossref_primary_10_1016_j_intimp_2023_109882
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1016/j.annonc.2022.08.036
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 10_1016_j_annonc_2022_08_036
GroupedDBID ---
-E4
.2P
.86
.I3
.XZ
.ZR
08P
0R~
0U7
1TH
23M
2WC
4.4
482
48X
53G
5GY
5VS
5WA
6.Y
6J9
70D
AAEDW
AAJKP
AAJQQ
AAKAS
AAKUH
AALRI
AAMVS
AAOGV
AAPNW
AAUQX
AAXUO
AAYXX
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNKS
ABOCM
ABQLI
ABQTQ
ABSAR
ABSMQ
ABVKL
ABZBJ
ACGFO
ACGFS
ACMRT
ACPQN
ACPRK
ACUFI
ACUTO
ADBBV
ADEYI
ADHKW
ADHZD
ADJQC
ADOCK
ADRIX
ADRTK
ADVLN
ADYVW
ADZCM
ADZXQ
AEGPL
AEGXH
AEHUL
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AEWNT
AFETI
AFIYH
AFJKZ
AFOFC
AFSHK
AFXEN
AGINJ
AGKEF
AGKRT
AGSYK
AHMBA
AHXPO
AIAGR
AIJHB
AITUG
AKRWK
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMRAJ
APIBT
APWMN
AQKUS
ASPBG
ATTQO
AVWKF
AXUDD
AZFZN
BAWUL
BAYMD
BGNMA
BHONS
BTRTY
BVRKM
BZKNY
C1A
CAG
CDBKE
CITATION
CKLRP
COF
CS3
CZ4
DAKXR
DIK
DILTD
DL5
D~K
E3Z
EBS
EE~
EJD
EX3
F9B
FDB
FEDTE
GJXCC
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
I09
IH2
IHE
IOX
J21
KAQDR
KDC
KOM
KOP
KQ8
KSI
KSN
LAK
M-Z
M41
M49
M4Y
MBLQV
MHKGH
N9A
NCXOZ
NGC
NOYVH
NTWIH
NU-
NU0
NVLIB
O9-
OAWHX
ODMLO
OJQWA
OK1
OVD
P2P
P6G
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RNI
ROL
ROX
ROZ
RPX
RW1
RXO
RZC
RZE
RZF
RZO
SDH
TCURE
TEORI
TJX
TMA
TR2
U2A
W8F
WOQ
WOW
X7H
YAYTL
YFH
YKOAZ
ZKX
ZXP
~91
ID FETCH-LOGICAL-c1426-7ba6bec20b666929e93ca2cd1aa030d83aab3aed1a9e5c57cc99bff984f9f9883
ISSN 0923-7534
IngestDate Fri Nov 22 00:04:09 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1426-7ba6bec20b666929e93ca2cd1aa030d83aab3aed1a9e5c57cc99bff984f9f9883
OpenAccessLink https://doi.org/10.1016/j.annonc.2022.08.036
ParticipantIDs crossref_primary_10_1016_j_annonc_2022_08_036
PublicationCentury 2000
PublicationDate 2022-09-00
PublicationDateYYYYMMDD 2022-09-01
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-00
PublicationDecade 2020
PublicationTitle Annals of oncology
PublicationYear 2022
SSID ssj0006929
Score 2.4432194
SourceID crossref
SourceType Aggregation Database
StartPage S1406
Title LBA3 Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ1Lj9MwEMet7iIhLoineMsHDqCQiMTOi1sLhRZ2uWyRuEVjJ9nNKo9quzksn4SPyziOk8CuEHvgErVua6Wen2zP5D9jQl6Cl_q-EOiWcBds7rrShjjgNqRqMRSB9LnKRl4dhV-_Rx-WfDmbmTPnxrb_amlsQ1urzNlrWHvoFBvwNdocr2h1vP6T3Q8Wc1Wy3MjHdZy1rZozG3svyq5Kbn1slRdoxkZe9GHXzfpAxQeURqPdWcW2KIuqrUBokaXRCVRZCXVTgVbR7dryfKfzU0ALE5XSUyOAK2DaVMUP_NH2BBdKa71eW90JIdPd8Fi9uanlb_H9FUDdp404C2fufHLGJ0MnoIO2h0PboulPtNo4q6FRJWbhpGotegHbZ_NZH-NA99iIuIZgpcdsdKz4dN5mbDLxHqGjGFy5JOjoxKkDdY3_xVHdd0Vb2RUVuP9YGQe9opHCnSa6l0T1kqjzO1mwR254OMl17vz6y7ALCGJP13ns79ykbXbawsv3MtkWTfY3mzvkdu-Y0Lkm6i6ZZfU9cvOwl17cJz8VWHQAiyqw6GWw6AQs-gqxek01VHSEiiJU1EBFDVTvaI8UVUhRoBOk3tARKNoBRREo2gH1gHz7uNy8X9n9sR62dHE_aIcCApw5vLcCXWccpSxmEjyZugC44qQRAxAMMnwfZ770QynjWOR5HPE8xmvEHpJ9HL7sEaEBz0WUBqEQEHE3iwD8KHJZCCzNUp77j4ltRjXZ6uotyd9s-eSa339Kbo24PiP752dt9pzs7dL2RUfDLz6NleI
link.rule.ids 315,782,786,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=LBA3+Treatment+with+tumor-infiltrating+lymphocytes+%28TIL%29+versus+ipilimumab+for+advanced+melanoma%3A+Results+from+a+multicenter%2C+randomized+phase+III+trial&rft.jtitle=Annals+of+oncology&rft.au=Haanen%2C+J.B.A.G.&rft.au=Rohaan%2C+M.&rft.au=Borch%2C+T.H.&rft.au=van+den+Berg%2C+J.H.&rft.date=2022-09-01&rft.issn=0923-7534&rft.volume=33&rft.spage=S1406&rft_id=info:doi/10.1016%2Fj.annonc.2022.08.036&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_annonc_2022_08_036
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0923-7534&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0923-7534&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0923-7534&client=summon